M&T Bank’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-28,373
Closed -$442K 1683
2016
Q4
$442K Buy
28,373
+11,373
+67% +$189K ﹤0.01% 1106
2016
Q3
$327K Buy
17,000
+3,621
+27% +$43K ﹤0.01% 1237
2016
Q2
$159K Sell
13,379
-2,441
-15% -$40.3K ﹤0.01% 1484
2016
Q1
$287K Buy
+15,820
New +$288K ﹤0.01% 1295

Other funds holding COLL

M&T Bank's COLL Position: Q1 2017 in Review

M&T Bank sold out of Collegium Pharmaceutical (COLL) in Q1 2017, closing a stake of 28,373 shares — an estimated $442K sold.

M&T Bank first reported a position in COLL in Q1 2016 and held it in 4 quarters. The position peaked at $442K in Q4 2016. 83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

  • M&T Bank reported no remaining Collegium Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • M&T Bank sold 28,373 Collegium Pharmaceutical shares in Q1 2017, an estimated $442K.
  • M&T Bank first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 4 quarters.
  • M&T Bank's Collegium Pharmaceutical position peaked at $442K in Q4 2016.
  • 83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on M&T Bank's 13F filing for Q1 2017, filed 10 May 2017.